BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, April 23, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

June 7, 2019

View Archived Issues

Aqualung Therapeutics wins award to support development of therapies for ARDS

Read More

In vitro study identifies factors responsible for the SPARCL of youth

Read More

AMG-172 investigated in relapsed/refractory renal cell carcinoma

Read More

Axovant presents 6-month follow-up data from first cohort of SUNRISE-PD study

Read More

Enlivex Therapeutics provides clinical update for its OTS Allocetra therapy for severe sepsis

Read More

Early signals of clinical activity observed in phase I study of KX2-391 in patients with psoriasis

Read More

TAXIS Pharmaceuticals identifies new antibacterials

Read More

Principia Biopharma patents proteasome subunit beta type-8 and/or beta type-9 inhibitors

Read More

The University of Kansas, Victoria Link disclose mu-opioid receptor agonists

Read More

Bristol-Myers Squibb presents Toll-like receptor 7, 8 and/or 9 antagonists

Read More

MAP3K5 inhibitors discovered at Sidecar Therapeutics

Read More

Apalutamide + ADT in mCSPC: first data from the TITAN study presented

Read More

Nasally administered olanzapine INP-105 more rapidly absorbed than other formulations

Read More

Phase III ASCERTAIN trial of ASTX-727 in MDS or CMML meets primary endpoint

Read More

Purdue initiates phase I study of nalmefene hydrochloride for emergency treatment of opioid overdose

Read More

Goldfinch begins first-in-human study of GFB-887 for kidney disease

Read More

NeRRe reports data from phase IIb study of orvepitant in chronic cough

Read More

Novartis presents data from LINC3 study on osilodrostat in patients with Cushing's disease

Read More

American BriVision reports phase II data on ABV-1504 for major depressive disorder

Read More

Anti-ENG antibody-drug conjugates show preclinical efficacy for the treatment of Ewing's sarcoma

Read More

Identification and characterization of a fluorinated indole-imidazole as a 5-HT7 receptor agonist

Read More

Novel berberine-metformin hybrid with improved antihyperlipidemic effect for type 2 diabetes

Read More

Phase I results presented for ERK-1/2 inhibitor LY-3214996 in advanced cancer

Read More

Preliminary activity seen with estrogen receptor alpha antagonist H3B-6545 in breast cancer

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 23, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 21, 2026
  • Green arrow on blue abstract background

    Psychedelic space expanding on Trump’s EO

    BioWorld
    Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
  • Illustration of metastatic cancer

    At AACR: Epigenetic fingerprints in metastases track tumor origin

    BioWorld
    When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
  • In the clinic for April 21, 2026

    BioWorld
    Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing